Showing results (21-30 of 639) with videos related to
Sort By:
Pageof 64
Melanoma Research|January 23, 2010
Old and new serological biomarkers in melanoma: where we are in 2009Roger Mouawad, Jean-Philippe Spano, David KhayatCritical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.Bulletin Du Cancer|February 4, 2005
[HPV and cancer]Jean-Philippe Spano, Anne-Genevieve Marcelin, Guislaine CarcelinBulletin Du Cancer|July 9, 2004
[Cyclooxygenase 2 inhibitors and lung carcinoma]Jean-Philippe Spano, Kader Chouahnia, Jean-François MorèreBulletin Du Cancer|May 19, 2005
[Cyclooxygenase 2 inhibitors and lung carcinoma]Jean-Philippe Spano, Kader Chouahnia, Jean-François MorèreExpert Review of Anticancer Therapy|April 13, 2007
Cetuximab plus irinotecan in refractory colorectal cancer patientsMarian Gil Delgado, Jean-Philippe Spano, David KhayatThe Oncologist|June 28, 2011
Current targeted therapies in breast cancer: clinical applications in the elderly womanJean-Philippe Spano, Claire Falandry, Pascal Chaibi, et al.Critical Reviews in Oncology/Hematology|January 22, 2008
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancerJean Philippe Spano, Gérard Milano, Stéphane Vignot, et al.Bulletin Du Cancer|June 30, 2015
[Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes]Benjamin BesseBulletin Du Cancer|February 4, 2006
[Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives]Jean-Philippe Spano, Guislaine Carcelain, Christine Katlama, et al.Pageof 64